(Bold for FDA approved)
• Blocks dopamine 2 receptors, reducing positive symptoms of psychosis
• With injection, psychotic symptoms can improve within a few days, but it may take 1–2 weeks for notable improvement
• With oral formulation, psychotic symptoms can improve within 1 week, but it may take several weeks for full effect on behavior
• Neuroleptic-induced deficit syndrome
• Drug-induced parkinsonism
• Insomnia, restlessness, agitation, sedation
• Tardive dyskinesia (risk increases with duration of treatment and with dose)
• Risk of potentially irreversible involuntary dyskinetic movements may increase with cumulative dose and treatment duration
• Galactorrhea, amenorrhea
• Tachycardia
• Weight gain
• Hypomania
• Rare eosinophilia
• Rare neuroleptic malignant syndrome may cause hyperpyrexia, muscle rigidity, delirium, and autonomic instability with elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis), and acute renal failure
• Rare seizures
• Rare jaundice, leukopenia
• As a class, antipsychotics are associated with an increased risk of death and cerebrovascular events in elderly patients with dementia; not approved for treatment of dementia-related psychosis
common
not usual
• Wait
• Wait
• Wait
• For drug-induced parkinsonism, add an anticholinergic agent
• Beta blockers, benzodiazepines, or serotonin 2A antagonists (e.g., mirtazapine, cyproheptadine) may reduce akathisia
• Reduce the dose
• For sedation, give at night
• Switch to an atypical antipsychotic
• Weight loss, exercise programs, and medical management for high BMIs, diabetes, dyslipidemia
• Metformin may help prevent or reverse antipsychotic-induced weight gain
• Oral 3–6 mg/day in divided doses
• Intramuscular 40–120 mg every 1–4 weeks
• Tablet 0.5 mg, 3 mg
• Injection 20 mg/mL, 100 mg/mL
• Should periodically reevaluate long-term usefulness in individual patients, but treatment may need to continue for many years
• No
• Oral: recommended to take half or less of usual adult dose
• Intramuscular: recommended dose schedule generally 10–20 mg every 15 days
• Use with caution
• Oral: recommended to take half or less of usual adult dose
• Use with caution
• Oral: recommended to take half or less of usual adult dose
• Intramuscular: recommended initial dose generally 5 mg; recommended dose schedule generally 10–20 mg every 15 days
• Oral: recommended to take half or less of usual adult dose
• Although conventional antipsychotics are commonly used for behavioral disturbances in dementia, no agent has been approved for treatment of elderly patients with behavioral symptoms of dementia such as agitation
• Elderly patients with dementia-related psychosis treated with antipsychotics are at increased risk of death compared to placebo, and also have an increased risk of cerebrovascular events
• Not recommended for use in children
• Not recommended for use during pregnancy
• There is a risk of abnormal muscle movements and withdrawal symptoms in newborns whose mothers took an antipsychotic during the third trimester; symptoms may include agitation, abnormally increased or decreased muscle tone, tremor, sleepiness, severe difficulty breathing, and difficulty feeding
• Reports of drug-induced parkinsonism, jaundice, hyperreflexia, hyporeflexia in infants whose mothers took a conventional antipsychotic during pregnancy
• Psychotic symptoms may worsen during pregnancy and some form of treatment may be necessary
• Atypical antipsychotics may be preferable to conventional antipsychotics or anticonvulsant mood stabilizers if treatment is required during pregnancy
• Some drug is found in mother’s breast milk
• Recommended either to discontinue drug or bottle feed
Based on data Published online by Cambridge University Press
Compiled by Dr. Jash Ajmera